title: [AWMF-guideline: disorders related to cannabis].
abstract: Actually, guidelines for treatment of substance-related disorders were written under the overall control of the DG-Sucht e. V. and the DGPPN e. V. This appears within the framework of the Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaft (AWMF). The leading objective of these guidelines is the description of the current scientifically proven and evidence-based medicine in addiction to derive recommendations to therapy. In this context, the guideline for treatment of cannabis-related disorders is introduced.
authors.affiliation: Rheinische Kliniken Essen, Klinik für Psychiatrie und Psychotherapie, Universität Duisburg-Essen. udo.bonnet@uni-essen.de
authors.forename: U
authors.initials: U
authors.lastname: Bonnet
authors.forename: K
authors.initials: K
authors.lastname: Harries-Hedder
authors.forename: F M
authors.initials: FM
authors.lastname: Leweke
authors.forename: U
authors.initials: U
authors.lastname: Schneider
authors.forename: P
authors.initials: P
authors.lastname: Tossmann
mesh_terms: D002188:Cannabis / Q000633:toxicity; D004347:Drug Interactions; D019317:Evidence-Based Medicine; D006801:Humans; D002189:Marijuana Abuse / Q000145:classification / Q000175:diagnosis / Q000628:therapy*; D001523:Mental Disorders / Q000150:complications / Q000523:psychology; D011605:Psychoses, Substance-Induced / Q000523:psychology; D012008:Recurrence